Immunogenicity of hepatitis B vaccine in premature infants.
dc.contributor.author | Sanpavat, S | en_US |
dc.contributor.author | Poovorawan, Y | en_US |
dc.contributor.author | Chittinand, S | en_US |
dc.contributor.author | Bhongsvej, S | en_US |
dc.contributor.author | Thaithumyanon, P | en_US |
dc.date.accessioned | 2009-05-27T15:16:25Z | |
dc.date.available | 2009-05-27T15:16:25Z | |
dc.date.issued | 1994-03-01 | en_US |
dc.description | The Southeast Asian Journal of Tropical Medicine and Public Health. | en_US |
dc.description.abstract | The immunogenicity of plasma-derived hepatitis B vaccine was studied in 39 premature neonates, whose weights were 1,800-2,400 g and gestational ages 32-37 weeks. All maternal antiHBc antibody were negative. Dosage of 5 micrograms of hepatitis B vaccine (Pasteur vaccine) was given at 0, 1, 2 and 12 months after birth. At the ages of 1, 2, 4, 9, 12 and 13 months, antiHBs antibody was found in 7.7%, 20%, 69.7%, 81.4%, 77.3% and 89.5%, respectively, while the geometric mean titer in this seropositive group, starting at age 2 months was 37, 121, 113, 69 and 1,016 mIU/ml. There was no severe reaction attributed to the vaccination. The result indicated that the vaccine was immunogenic. Although the conversion rate was low after primary injection, a satisfactory response developed at age 4 months after 3 doses of vaccine. | en_US |
dc.description.affiliation | Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand. | en_US |
dc.identifier.citation | Sanpavat S, Poovorawan Y, Chittinand S, Bhongsvej S, Thaithumyanon P. Immunogenicity of hepatitis B vaccine in premature infants. The Southeast Asian Journal of Tropical Medicine and Public Health. 1994 Mar; 25(1): 93-5 | en_US |
dc.identifier.uri | https://imsear.searo.who.int/handle/123456789/32363 | |
dc.language.iso | eng | en_US |
dc.source.uri | https://www.tm.mahidol.ac.th/seameo/publication.htm | en_US |
dc.subject.mesh | Age Factors | en_US |
dc.subject.mesh | Birth Weight | en_US |
dc.subject.mesh | Female | en_US |
dc.subject.mesh | Follow-Up Studies | en_US |
dc.subject.mesh | Gestational Age | en_US |
dc.subject.mesh | Hepatitis B Antibodies --blood | en_US |
dc.subject.mesh | Hepatitis B Vaccines --immunology | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Immunization Schedule | en_US |
dc.subject.mesh | Infant | en_US |
dc.subject.mesh | Infant, Newborn | en_US |
dc.subject.mesh | Infant, Premature --blood | en_US |
dc.subject.mesh | Male | en_US |
dc.title | Immunogenicity of hepatitis B vaccine in premature infants. | en_US |
dc.type | Clinical Trial | en_US |
dc.type | Journal Article | en_US |
dc.type | Research Support, Non-U.S. Gov't | en_US |
Files
License bundle
1 - 1 of 1